Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Conditions
- Idiopathic Pulmonary Fibrosis
Interventions
- OTHER: Therapeutic Plasma Exchange
- DRUG: Rituximab
- DRUG: Intravenous immunoglobulin
- DRUG: Treatment as Usual
Sponsor
University of Alabama at Birmingham